 "A health worker tests a visitor for Covid-19 testing at the RML Hospital in Lucknow, Saturday, Aug. 7, 2021. (PTI Photo/Nand Kumar)")
USA’s Johnson & Johnson (J&J) has sought the Indian drug regulator’s permission to test its Covid-19 vaccine on the 12 to 17 age group, joining a clutch of other firms seeking to inoculate children against a disease that has killed 433,589 people in the country.
The company said on Friday that it has submitted an application to the Central Drugs Standard Control Organisation (CDSCO) on August 17 to conduct a study.
Studies have shown the J&J vaccine has 66 percent efficacy against preventing moderate to severe Covid-19, and about 85 percent efficacy against severe cases.
“Johnson & Johnson is committed
